Excessive anxiety in IBD patients is unnecessary for COVID-19.
作者信息
Wang Hong-Gang, Xie Rui, Ma Tian-Heng, Yang Xiao-Zhong
机构信息
Department of Gastroenterology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
Department of Gastroenterology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
出版信息
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):e121-e122. doi: 10.1016/j.clinre.2020.03.001. Epub 2020 May 12.
Abstract
摘要
相似文献
1
Excessive anxiety in IBD patients is unnecessary for COVID-19.炎症性肠病患者对新冠病毒过度焦虑是没有必要的。
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):e121-e122. doi: 10.1016/j.clinre.2020.03.001. Epub 2020 May 12.
2
Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor and in Inflammatory Bowel Disease.年龄、炎症和疾病部位是炎症性肠病中 SARS-CoV-2 受体肠道表达的关键决定因素。
Gastroenterology. 2020 Sep;159(3):1151-1154.e2. doi: 10.1053/j.gastro.2020.05.030. Epub 2020 May 12.
3
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.血管紧张素转换酶2（ACE2）受体、哮喘与严重新型冠状病毒肺炎感染风险
Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3.
4
COVID-19 challenging cell biology.新冠病毒对细胞生物学构成挑战。
Protoplasma. 2020 May;257(3):619-620. doi: 10.1007/s00709-020-01506-z. Epub 2020 Apr 24.
5
Possible protective role of contact Lens against SARS COV 2.隐形眼镜对严重急性呼吸综合征冠状病毒2的潜在保护作用。
J Fr Ophtalmol. 2020 Sep;43(7):e233-e234. doi: 10.1016/j.jfo.2020.05.004. Epub 2020 Jun 6.
6
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.2019冠状病毒病与心血管疾病：我们已知的、我们自认为已知的以及我们需要了解的情况。
J Mol Cell Cardiol. 2020 Jul;144:12-14. doi: 10.1016/j.yjmcc.2020.04.026. Epub 2020 Apr 24.
7
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.肾素-血管紧张素抑制对ACE2（血管紧张素转换酶2）和TMPRSS2（跨膜丝氨酸蛋白酶2）表达的影响：对2019冠状病毒病的见解
Hypertension. 2020 Oct;76(4):e29-e30. doi: 10.1161/HYPERTENSIONAHA.120.15782. Epub 2020 Jul 14.
8
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.SARS-CoV-2 进入分子 ACE2 和 TMPRSS2 在 IBD 患者肠道中的表达。
Inflamm Bowel Dis. 2020 May 12;26(6):797-808. doi: 10.1093/ibd/izaa085.
9
The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.炎症性肠病患者中新型冠状病毒肺炎的发病率及转归：一项快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e132-e133. doi: 10.1093/ibd/izaa170.
10
Androgen-driven COVID-19 infection - is testosterone an enemy or a friend?雄激素驱动的新冠病毒感染——睾酮是敌是友？
Horm Mol Biol Clin Investig. 2020 Jun 29;41(2):hmbci-2020-0027. doi: 10.1515/hmbci-2020-0027.
引用本文的文献
1
Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients' Concerns.新冠疫情期间的炎症性肠病：发病率及患者担忧的前瞻性队列研究
Middle East J Dig Dis. 2022 Jan;14(1):24-33. doi: 10.34172/mejdd.2022.252. Epub 2022 Jan 30.
2
Psychosocio-economic impacts of COVID-19 on gastroenterology and endoscopy practice.新冠疫情对胃肠病学和内镜诊疗实践的社会心理经济影响
Gastroenterol Rep (Oxf). 2021 Apr 10;9(3):205-211. doi: 10.1093/gastro/goab012. eCollection 2021 Jun.
3
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.COVID-19 大流行期间急性重度溃疡性结肠炎患者的评估、内镜检查和治疗（PROTECT-ASUC）：一项多中心、观察性、病例对照研究。
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-281. doi: 10.1016/S2468-1253(21)00016-9. Epub 2021 Feb 2.
4
Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy.难治性乳糜泻与新冠疫情：意大利北部高发病例情况的研究结果
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):e115-e120. doi: 10.1016/j.clinre.2020.07.026. Epub 2020 Aug 22.
5
Bowel ulceration following tocilizumab administration in a COVID-19 patient.一名COVID-19患者使用托珠单抗后出现肠道溃疡。
BMJ Open Gastroenterol. 2020 Aug;7(1). doi: 10.1136/bmjgast-2020-000484.
6
The occurrence of diarrhea in COVID-19 patients.新冠病毒肺炎患者腹泻的发生情况。
Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):284-285. doi: 10.1016/j.clinre.2020.03.017. Epub 2020 Apr 3.
本文引用的文献
1
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus.腹泻可能被低估了：2019新型冠状病毒中的一个缺失环节。
Gut. 2020 Jun;69(6):1141-1143. doi: 10.1136/gutjnl-2020-320832. Epub 2020 Feb 26.
4
COVID-19: what is next for public health?新冠疫情：公共卫生的下一步走向何方？
Lancet. 2020 Feb 22;395(10224):542-545. doi: 10.1016/S0140-6736(20)30374-3. Epub 2020 Feb 13.
5
Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.定量蛋白质组学分析揭示了炎症性肠病中烟酰胺腺嘌呤二核苷酸代谢和 CD38 的失调。
Biomed Res Int. 2019 Apr 23;2019:3950628. doi: 10.1155/2019/3950628. eCollection 2019.
6
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.炎症性肠病患者的生活质量：系统评价和荟萃分析 - 第一部分。
Inflamm Bowel Dis. 2018 Mar 19;24(4):742-751. doi: 10.1093/ibd/izx100.
7
Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease.抑郁和焦虑症状与炎症性肠病的临床复发独立相关。
Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.e1. doi: 10.1016/j.cgh.2015.12.045. Epub 2016 Jan 25.
Zotero 插件